About Us

Home / About Us / Our Team / 
Tracy Olson

Tracy Olson, Ph.D.


Tracy Olson joined as Vice President of Program Management in April, 2019. Prior to joining Apellis Tracy held a similar position at Ironwood Pharmaceuticals for 7 years where she was responsible for managing the R&D portfolio including the GI, gout, and early pipeline. In addition, Tracy has developed the program management function at Synta Pharmaceuticals where she was head of Program Management and Quality Assurance, at Elixir Pharmaceuticals where she was Vice President of Program Management and Regulatory Affairs, and at Alkermes where she was head of Program Management. Tracy began her career as a Damon Runyon-Walter Winchell Cancer Research Fund Postdoctoral Fellow at the National Institutes of Health and Tufts University School of Medicine. Tracy earned a Ph.D. in biochemistry from the Johns Hopkins University School of Medicine and a BA in biology and a BS in chemistry from the University of Delaware.
Apellis logo
© Apellis Pharmaceuticals 2019.